1Nevrologisk avdeling, Rikshospitalet, 0027 Oslo. arve.dahl@rikshospitalet.no
Statins (cholesterol-lowering drugs) show a moderate risk reduction for ischaemic stroke in patients with atherosclerotic disease. However, their benefit for secondary stroke prevention in all patients remains unclear due to varied stroke causes.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: